101
Participants
Start Date
June 30, 2013
Primary Completion Date
July 31, 2015
Study Completion Date
July 31, 2015
Eribulin mesylate
1.4 mg/m2 (as eribulin 1.23 mg/m2) day by 2-5 minutes IV on Day 1 and 8 every 21 days
National Cancer Center, Goyang-si
Seoul National University Bundang Hospital, Seongnam-si
Ajou University Hospital, Suwon
Chungbuk National University Hospital, Cheongju-si
Dong-A University Hospital, Busan
Kyungpook National University Hospital, Daegu
Gachon University Gil Medical Center, Incheon
Seoul National University Hospital, Seoul
Severance Hospital, Seoul
Samsung Medical Center, Seoul
Korea University Anam Hospital, Seoul
Asan Medical Center, Seoul
Korea University Guro Hospital, Seoul
Ulsan University Hospital, Ulsan
Eisai Korea Inc.
INDUSTRY